Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
Development. 2013 Jun;140(12):2472-83. doi: 10.1242/dev.093187.
Insulin-secreting pancreatic β-cells are essential regulators of mammalian metabolism. The absence of functional β-cells leads to hyperglycemia and diabetes, making patients dependent on exogenously supplied insulin. Recent insights into β-cell development, combined with the discovery of pluripotent stem cells, have led to an unprecedented opportunity to generate new β-cells for transplantation therapy and drug screening. Progress has also been made in converting terminally differentiated cell types into β-cells using transcriptional regulators identified as key players in normal development, and in identifying conditions that induce β-cell replication in vivo and in vitro. Here, we summarize what is currently known about how these strategies could be utilized to generate new β-cells and highlight how further study into the mechanisms governing later stages of differentiation and the acquisition of functional capabilities could inform this effort.
胰岛素分泌的胰腺β细胞是哺乳动物代谢的重要调节者。功能性β细胞的缺失会导致高血糖和糖尿病,使患者依赖外源性供应的胰岛素。最近对β细胞发育的深入了解,加上多能干细胞的发现,为生成新的β细胞用于移植治疗和药物筛选提供了前所未有的机会。利用在正常发育中被鉴定为关键因子的转录调节剂将终末分化的细胞类型转化为β细胞,以及鉴定在体内和体外诱导β细胞复制的条件方面也取得了进展。在这里,我们总结了目前已知的这些策略如何用于生成新的β细胞,并强调了进一步研究控制分化后期和获得功能能力的机制如何为这一努力提供信息。